Expression of cathepsin D in transitional cell bladder tumours

Area of Science:

• Oncology
• Pathology
• Biomarker Research

Background:

• Cathepsin D is a lysosomal aspartic protease implicated in tumor progression and metastasis.
• Its role in bladder cancer, particularly in relation to tumor characteristics and prognosis, requires further elucidation.

Purpose of the Study:

• To investigate the expression patterns of Cathepsin D in bladder tumors.
• To correlate Cathepsin D expression with clinicopathological features and patient prognosis.

Main Methods:

• Immunohistochemical analysis of Cathepsin D expression in 177 biopsy specimens of bladder tumors.
• Correlation of Cathepsin D expression in transitional carcinoma cells, umbrella cells, and tissue macrophages with tumor grade, stage, S-phase fraction, EGFR, and p53 protein.
• Univariate and multivariate survival analyses to assess prognostic significance.

Main Results:

• Strong Cathepsin D expression was observed in 40% of transitional carcinoma cells, associated with muscle-invasive growth, higher grade, increased S-phase fraction, and EGFR overexpression.
• Cathepsin D-positive umbrella cells were found in 29% of tumors, linked to low-grade papillary tumors with low S-phase fraction.
• Cathepsin D-positive macrophages at the invasion front (34% of tumors) correlated with inflammatory cell infiltration, EGFR, and p53 overexpression, and were independent prognostic factors in advanced tumors.

Conclusions:

• Cathepsin D expression in bladder cancer cells and tumor-associated macrophages is associated with aggressive clinicopathological features.
• Cathepsin D expression, particularly in macrophages, serves as an independent prognostic factor for advanced bladder tumors.
• These findings suggest Cathepsin D's potential as a biomarker for predicting bladder cancer progression and outcome.